Results 161 to 170 of about 7,979,963 (279)
The ambiguity of working class interests in Brazilian road transport: the case of self-employed truckers. [PDF]
Nowak J.
europepmc +1 more source
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim +7 more
wiley +1 more source
Predictors of exclusive breastfeeding intention among pregnant working-class women in Wakiso District, central Uganda: a cross-sectional study. [PDF]
Nekesa C +5 more
europepmc +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Knowledge and Attitude of Working-Class Women Towards Exclusive Breastfeeding in Kwara State, Nigeria: Implications for Counselling Practice. [PDF]
Adegboyega LO +4 more
europepmc +1 more source
Working-Class Men's Constructions of Help-Seeking When Feeling Depressed or Sad. [PDF]
Mahalik JR, Dagirmanjian FR.
europepmc +1 more source
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both +7 more
wiley +1 more source
Preschool teachers provide fewer participation opportunities to working-class students than those from more privileged backgrounds. [PDF]
Doyle L, Cimpian A, Goupil L, Goudeau S.
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source

